Medicine Wellness Health 

Asahi Kasei receives prestigious Okochi Memorial Prize for its microcrystalline cellulose (MCC) Ceolus™ UF grade used for excipient in tablets

Solving tableting issues, improving content uniformity, and achieving challenging dosage form Novi, Michigan, and Düsseldorf – May 13, 2025 – On March 25, Japanese technology company Asahi Kasei was awarded the prestigious Okochi Memorial Prize, which acknowledges significant contributions to the areas of production engineering, production technology R&D, and the implementation of high-level production methods in Japan. The Okochi Memorial Foundation recognized the contribution of Asahi Kasei“s MCC Ceolus™ UF grade to solving challenges with poor compactibility and flowability, two pressing formulation issues for pharmaceutical companies in the development and…

Mehr...
Medicine Wellness Health 

Bionova Scientific today announced it has licensed ATUM“s proprietary Leap-In Transposase® transposon-based gene delivery

ATUM“s Leap-In Transposase technology can achieve high levels of gene integration, resulting in a large number of cells with the desired gene insertion, precise integration as a single copy into the host cell’s genome, and integration into multiple locations within the genome, reducing the risk of gene silencing or other adverse effects. When used in a cell line development program, Leap-In Transposase technology delivers productive, stable, and robust cell lines, including at the stable pool stage. Bionova possesses extensive expertise across the biologics lifecycle. By combining Bionova“s cell line development…

Mehr...
Medicine Wellness Health 

Ken Shinomiya becomes Leader of Asahi Kasei“s Healthcare Sector

Leading the way for the sector“s continued growth and commitment to improving patient outcomes Chelmsford, MA, Novi, MI, Düsseldorf, Germany and Tokyo, Japan, April 24, 2025 – Asahi Kasei has appointed Ken Shinomiya, President of Asahi Kasei Life Science, as the Leader of its Healthcare Sector succeeding Richard Packer. Under Shinomiya, Asahi Kasei“s Healthcare Sector will further advance its portfolio and global presence of pharmaceuticals, life science, and critical care products and services. Having served as Vice President of Strategy at ZOLL Medical Corporation from fiscal 2016 to fiscal 2017,…

Mehr...
Medicine Wellness Health 

Asahi Kasei establishes Asahi Kasei Life Science to drive its bioprocess businesses forward

Serving as a premium partner for pharmaceutical companies by contributing to the safety and productivity of their manufacturing process Düsseldorf – April 8, 2025 – To meet growing demand from the pharmaceutical industry, Asahi Kasei has established Asahi Kasei Life Science to operate its bioprocess businesses under a new organizational structure. Through this change, the company can offer the industry more agile and focused services, deeper innovation in bioprocess solutions, and stronger support in emerging modalities. As part of the evolving pharmaceutical ecosystem, where multiple stakeholders are involved in drug…

Mehr...
Medicine Wellness Health 

ELVeS Radial: Gentle varicose vein laser therapy also impresses with good cosmetic results

Varicose veins are not only a cosmetic problem, they can also cause significant discomfort – but with the innovative, minimally invasive ELVeS® Radial® laser therapy from biolitec®, there is now a gentle and effective solution for those affected. Jena, 20.03.2025 – Innovative technologies have taken the treatment of varicose veins to a new level. At the forefront is biolitec®’s ELVeS® Radial® Laser Therapy, which is not only medically effective but also delivers cosmetically convincing results. Many of those affected suffer from heavy, tired legs, swelling and pain, especially after standing…

Mehr...

Experienced Industry Leader Tom Arnold Appointed as Chief Executive Officer of ViCentra

Utrecht, The Netherlands – February 26, 2025 ViCentra B.V., the company behind Kaleido, one of the world’s smallest, lightest, and most precise insulin patch pump and automated insulin delivery (AID) system, today announced the appointment of Tom Arnold as Chief Executive Officer. Tom brings almost 25 years of extensive leadership experience in diabetes and medical technology and has a strong track record in spearheading commercialization initiatives, business strategy, and product launches for leading medical device companies. He has held key leadership roles at Medtronic, PROCEPT BioRobotics, Boston Scientific, and Sorin…

Mehr...
Medicine Wellness Health 

New methods for reliable evaluation of chemicals and pharmaceuticals

BioRegio STERN is a partner in the EU’s NAMWISE project (Stuttgart) – BioRegio STERN Management GmbH is a German partner in the European NAMWISE (New Approach Methodologies Within Integrated Safety & Efficacy evaluation of chemicals and pharmaceuticals) project, which is coordinated by the French Institut National de l’Environment Industriel et des Risques – INERIS. There are a total of 18 partners from eight countries involved in the project, and their aim is to introduce and integrate new methods (New Approach Methodologies, NAMs) to assess the safety and efficacy of chemicals…

Mehr...
Medicine Wellness Health 

HUMAN Diagnostics Announces the Launch of its Next Generation Clinical Chemistry Instruments

Primed for Precision. Built for Perfromance Wiesbaden, Germany – February 1, 2025 – HUMAN Diagnostics, a global player in in-vitro diagnostics, announces the launch of its advanced clinical chemistry instruments, scheduled to debut at Medlab Middle East in Dubai, from February 3-6, 2025. This milestone reflects HUMAN’s commitment to delivering innovative and reliable diagnostic solutions that meet the needs of modern laboratories worldwide. The launch is under the motto “ Primed for Precision. Built for Performance“ and will spotlight the next-generation HumaStar 300SR, HumaStar 200, and the HumaLyzer Primus NG,…

Mehr...
Medicine Wellness Health 

Proctocom 2024: RDG presents new standardized recommendations for LHP laser treatment of hemorrhoids

The recommendations of the LHP® Recommendation Development Group (RDG) published in November will contribute to the further standardization and refinement of laser hemorrhoidoplasty (LHP®) developed by biolitec® worldwide. Jena, 12.12.2024 – The LHP® Recommendation Development Group (RDG) published its recommendations for a standardized LHP® procedure on 23 November 2024.1 The group is made up of 49 surgeons with experience in the use of laser hemorrhoidoplasty – LHP® for short – developed by biolitec® for the minimally invasive treatment of hemorrhoids. The recommendations aim to improve the safety and efficacy of…

Mehr...

Asahi Kasei Pharma Strengthens Global Reach with Exclusive License Agreement for anti-CX3CR1 Antibody

Düsseldorf, Tokyo and Novi, Michigan – December 11, 2024 – Asahi Kasei Pharma has taken another step in its transformation into a global specialty pharmaceuticals company through a new licensing agreement with Chiome Bioscience for its humanized anti-CX3CR1 antibody. The partnership exemplifies Asahi Kasei Pharma“s Open Innovation platform, which addresses unmet medical needs through strategic collaboration and cutting-edge science. The anti-CX3CR1 antibody, currently in preclinical development, works by inhibiting CX3CR1, a receptor involved in immune cell migration to inflammatory sites. By accelerating its development, Asahi Kasei Pharma aims to bring…

Mehr...